Skip to main content

C21 Investments Inc.

Data quality: 83%
Also listed as CWLXF OTC
CXXIF
OTC Manufacturing Chemicals
$0.27
▼ $0.01 (-4.56%)
Mkt Cap: 36.43 M
Price
$0.30
Mkt Cap
36.43 M
Day Range
52-Week Range
Volume
Open —
50D / 200D Avg
50D / 200D Avg

Quick Summary

Key Takeaways

Capital efficient — spends only 1.35% of revenue on capex
ROIC of 1.44% — low return on invested capital

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)574.54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-13.31%
Above sector avg (-53.34%)
ROIC1.44%
Net Margin-13.18%
Op. Margin4.26%

Safety

Debt / Equity
N/A
Current Ratio0.94
Interest Coverage4.36

Valuation

PE (TTM)
-9.18
Below sector avg (-1.47)
P/B Ratio1.27
EV/EBITDA12.19
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -9.2 -1.5
P/B 1.3 1.6
ROE % -13.3 -53.3
Net Margin % -13.2 -41.5
Rev Growth 5Y % 1.8
D/E 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 29.22 M

All Fundamental Metrics

Growth
Revenue Growth (1Y) 574.54% Revenue Growth (3Y) -4.44%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 30.12 M Net Income (TTM) -3.97 M
ROE -13.31% ROA -7.07%
Gross Margin 41.70% Operating Margin 4.26%
Net Margin -13.18% Free Cash Flow (TTM) N/A
ROIC 1.44% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.94
Interest Coverage 4.36 Asset Turnover 0.54
Working Capital -452,928 Tangible Book Value -7.96 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.18 Forward P/E N/A
P/B Ratio 1.27 P/S Ratio 1.21
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 12.19 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 36.43 M Enterprise Value 36.43 M
Per Share
EPS (Diluted TTM) -0.03 Revenue / Share 0.24
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.35% FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023
Revenue 30.12 M 4.46 M 32.98 M 28.89 M
Net Income -3.97 M -74,404.0 10.92 M 293,211.0
EPS (Diluted) -0.03 0.00 0.09 0.00
Gross Profit 12.56 M 1.78 M 18.81 M 13.40 M
Operating Income 1.28 M 289,906.0 9.75 M 3.96 M
EBITDA
R&D Expenses
SG&A Expenses 11.28 M 1.49 M 9.06 M 9.45 M
D&A 1.71 M 207,225.0 1.82 M 1.84 M
Interest Expense 293,675.0 0.0 1.08 M 456,691.0
Income Tax 4.15 M 372,743.0 3.97 M 2.81 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023
Total Assets 57.00 M 55.23 M 61.85 M 58.31 M
Total Liabilities 28.32 M 24.25 M 26.87 M 24.00 M
Shareholders' Equity 28.68 M 30.97 M 34.98 M 34.32 M
Total Debt
Cash & Equivalents
Current Assets 7.50 M 8.14 M 10.28 M 8.74 M
Current Liabilities 7.96 M 15.05 M 14.73 M 14.97 M